UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000035653
Receipt No. R000040613
Official scientific title of the study Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty
Date of disclosure of the study information 2019/01/25
Last modified on 2019/01/24 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Denosumab prevents periprosthetic bone mineral density loss in the tibial metaphysis in total knee arthroplasty
Title of the study (Brief title) The effect of denosumab in periprosthetic bone mineral density
Region
Japan

Condition
Condition Primary osteoarthritis of knee
Classification by specialty
Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate whether denosumab treatment after total knee arthroplasty could prevent periprosthetic bone resorption in the patients of primary osteoarthritis.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes We measure periprosthetic bone mineral density using dual energy X-ray absorptiometry after total knee arthroplasty for 12 months.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment Pseudo-randomization

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Patients in the intervention group received 0.5 ug vitamin D3 (Alfacalcidol) daily and 60 mg denosumab every 6 months from the day after total knee arthroplasty for 12 months.
Interventions/Control_2 Patients in the control group received 0.5 ug active vitamin D3 (Alfacalcidol) daily from the day after total knee arthroplasty for 12 months.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria We include only patients with osteoporosis and primary osteoarthritis of the knee.
Key exclusion criteria We exclude patients who are undergoing revision surgery, and those who had previously taken anti-osteoporotic drugs or other medications known to influence bone mineral metabolism.
Target sample size 28

Research contact person
Name of lead principal investigator Atsushi Teramoto
Organization Sapporo Medical University School of Medicine
Division name Department of Orthopaedic Surgery
Address S-1, W-16, Chuo-ku, Sapporo, 060-8543, Hokkaido, Japan
TEL 01161112111(33330)
Email teramoto.atsushi@gmail.com

Public contact
Name of contact person Yasutaka Murahashi
Organization Sapporo Medical Univ. School of Medicine
Division name Department of Orthopaedic Surgery
Address S-1, W-16, Chuo-ku, Sapporo, 060-8543, Hokkaido, Japan
TEL 01161112111(33330)
Homepage URL
Email yayayaya1126@yahoo.co.jp

Sponsor
Institute Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor None
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 札幌医科大学附属病院(北海道) Sapporo Medical University Hospital

Other administrative information
Date of disclosure of the study information
2019 Year 01 Month 25 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 11 Month 05 Day
Anticipated trial start date
2014 Year 12 Month 11 Day
Last follow-up date
2018 Year 12 Month 27 Day
Date of closure to data entry
2018 Year 12 Month 27 Day
Date trial data considered complete
2018 Year 12 Month 27 Day
Date analysis concluded
2018 Year 12 Month 27 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2019 Year 01 Month 24 Day
Last modified on
2019 Year 01 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040613